Imidocarb dipropionate
Inquiry
| Post Date: | Jun 25,2015 |
| Expiry Date: | Jun 24,2016 |
| Detailed Description: |
Cas No. :55750-06-6
Payment Method: t/t Imidocarb dipropionate CAS: 55750-06-6 MF: C25H32N6O5 MW: 496.56 EINECS: 259-791-8 Product Categories: API Synonyms: N,N'-BIS[3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENYL]UREA DIPROPANOATE;LABOTEST-BB LT00053575;IMIDOCARB DIPROPIONATE;N,N'-bis(3-(4,5-dihydro-1H-imidazol-2-yl)-phenyl);N,N-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea) dipropionate;Imidocarb dipropionate VETRANAL;1,3-Bis[m-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea dipropionate;IMidocarb dipropiona mp 205 °C (dec.)(lit.) Chemical Properties White or off white crystalline powder Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites. Description: IMIZOL (imidocarb dipropionate) is a sterile solution containing 120 mg/mL of imidocarb dipropionate suitable for intramuscular or subcutaneous administration. Imidocarb is chemically described as N,N’-bis[3-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]urea dipropionate and has a molecular weight of 496.6. In addition to the active component, imidocarb dipropionate, the formulation also contains propionic acid (22.34 mg/mL), and water for injection. Imidocarb Dipropionate for Injection Features and Benefits •Two treatments two weeks apart •Simplifies treatment regimen •Injectable administration keeps the treatment under your control. •Eliminates the issue of treatment compliance. •Intramuscular or subcutaneous administration •Provides more versatility •Low volume dose treatment (3mg/lb), 100 lbs dog requires only 2.5 mL of IMIZOL per injection. Makes it cost effective and practical. Indications IMIZOL is a sterile solution containing imidocarb dipropionate for the treatment of dogs with clinical signs of babesiosis and/or demonstrated Babesia organisms in the blood. Canine babesiosis is a disease caused by tick-borne hematozoan organisms of the genus Babesia. IMIZOL is the only drug labeled for the treatment of canine babesiosis or of Babesia infected dogs. Imizol is a registered trademark of Schering-Plough Animal Health Corporation. |
| CAS Registry Number: | 55750-06-6 |
| Synonyms: | ;N,N-bis(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea) dipropionate;N,N-Bis[3-(4,5-dihydro-1H-imidazol-2-yl)phenyl]urea dipropanoate;Imidocarb dipropionate; |
| Molecular Formula: | C19H20N6O·2(C3H6O2) |
| Molecular Weight: | 496.57 |
| Molecular Structure: | 
|
| Company: | Hulumimi Pharmaceuticals [ China ] |
| Contact: | Toni Zhong |
| Tel: | 027-50756080 |
| Fax: | 0086-27-88048077-794 |
| Email: | toni@ycgmp.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
